Boston Scientific Corp
Research Boston Scientific Corp (BSX) on Bullrun: market cap USD 61.82B, P/E 17.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBSX
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 61.82B
- P/E17.3
- Financial periodQ2 2026
- RevenueUSD 5.44B
- Net incomeUSD 907.00M
- Free cash flow-USD 451.00M
- Gross margin70.7%
Valuation Snapshot
latest market cap is USD 61.82B; P/E is 17.3.
Peer valuation comparison
Latest P/E is 17.33x versus a Healthcare sector median of 24.61x (29.6% below).
Latest P/E is 17.33x versus a United States median of 23.85x (27.4% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 20.07B | USD 2.89B | USD 3.66B | 69.0% | 1.94 | USD 1.97B | USD 299.00M | USD 24.23B |
| FY2024 | USD 16.75B | USD 1.85B | USD 2.65B | 68.6% | 1.25 | USD 414.00M | USD 1.78B | USD 21.77B |
| FY2023 | USD 14.24B | USD 1.59B | USD 1.79B | 69.5% | 1.07 | USD 865.00M | USD 531.00M | USD 19.28B |
| FY2022 | USD 12.68B | USD 698.00M | USD 938.00M | 68.8% | 0.45 | USD 928.00M | USD 20.00M | USD 17.57B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 61.82B | 17.3 | n/a | n/a |
| 2025 | 2025-12-31 | USD 141.40B | 49.1 | n/a | n/a |
| 2024 | 2024-12-31 | USD 131.71B | 71.5 | n/a | n/a |
| 2023 | 2023-12-29 | USD 84.69B | 70.5 | n/a | n/a |
| 2022 | 2022-12-30 | USD 66.27B | 110.2 | n/a | n/a |
| 2021 | 2021-12-31 | USD 60.56B | 61.6 | n/a | n/a |
About Boston Scientific Corp
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
ETFs that hold Boston Scientific Corp
Boston Scientific Corp is one of the ten largest holdings of 3 ETFs that investors in Europe can buy, most traded first:
| ETF | Weight | TER |
|---|---|---|
| Xtrackers MSCI USA Health Care UCITS ETF 1D | 3.03% | 0.12% |
| iShares US Medical Devices UCITS ETF USD (Acc) | 6.56% | 0.25% |
| Franklin Future of Health and Wellness UCITS ETF | 3.05% | 0.30% |
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Boston Scientific Corp's market cap?
Boston Scientific Corp's market capitalization is USD 61.82B.
What is Boston Scientific Corp's P/E ratio?
Boston Scientific Corp's price-to-earnings (P/E) ratio is 17.3.
What does Boston Scientific Corp do?
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.